Literature DB >> 25791672

Evaluation of Elution and Mechanical Properties of High-Dose Antibiotic-Loaded Bone Cement: Comparative "In Vitro" Study of the Influence of Vancomycin and Cefazolin.

Eva Paz1, Pablo Sanz-Ruiz2, Juana Abenojar3, Javier Vaquero-Martín4, Francisco Forriol5, Juan Carlos Del Real1.   

Abstract

Use of antibiotic-loaded bone cements is one of the most effective methods for the prevention and treatment of prosthetic joint infection. However, there is still controversy about the optimal combination and doses of antibiotics that provide the maximum antimicrobial effect without compromising cement properties. In this study, vancomycin and cefazolin were added to a bone cement (Palacos R+G). Antibiotic release, fluid absorption, and mechanical properties were evaluated under physiological conditions. The results show that the type of antibiotic selected has an important impact on cement properties. In this study, groups with cefazolin showed much higher elution than those containing the same concentration of vancomycin. In contrast, groups with cefazolin showed a lower strength than vancomycin groups.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  antibiotic; bone cement–PMMA; elution; mechanical properties; water uptake

Mesh:

Substances:

Year:  2015        PMID: 25791672     DOI: 10.1016/j.arth.2015.02.040

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  20 in total

1.  The use of spacers (static and mobile) in infection knee arthroplasty.

Authors:  Luca Mazzucchelli; Federica Rosso; Antongiulio Marmotti; Davide Edoardo Bonasia; Matteo Bruzzone; Roberto Rossi
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

2.  Loading with vancomycin does not decrease gentamicin elution in gentamicin premixed bone cement.

Authors:  Sebastian P Boelch; Martin C Jordan; Joerg Arnholdt; Maximilian Rudert; Martin Luedemann; Andre F Steinert
Journal:  J Mater Sci Mater Med       Date:  2017-05-22       Impact factor: 3.896

Review 3.  Antibiotic-loaded Bone Cement as Prophylaxis in Total Joint Replacement.

Authors:  Javier Martínez-Moreno; Virginia Merino; Amparo Nácher; José Luis Rodrigo; Mónica Climente; Matilde Merino-Sanjuán
Journal:  Orthop Surg       Date:  2017-11       Impact factor: 2.071

Review 4.  The Use of Antibiotic Impregnated Cement Spacers in the Treatment of Infected Total Joint Replacement: Challenges and Achievements.

Authors:  Omid Shahpari; Alireza Mousavian; Nafise Elahpour; Michael-Alexander Malahias; Mohammad H Ebrahimzadeh; Ali Moradi
Journal:  Arch Bone Jt Surg       Date:  2020-01

5.  How Long Does Antimycobacterial Antibiotic-loaded Bone Cement Have In Vitro Activity for Musculoskeletal Tuberculosis?

Authors:  Jae Hoo Lee; Chang Dong Han; Sang-Nae Cho; Ick Hwan Yang; Woo Suk Lee; Seung-Hun Baek; Jae Won Shin; Khalid Elfadil Ibrahim Husein; Kwan Kyu Park
Journal:  Clin Orthop Relat Res       Date:  2017-08-09       Impact factor: 4.176

6.  Elution properties of a resorbable magnesium phosphate cement.

Authors:  Brandon L Roller; Aaron M Stoker; James L Cook
Journal:  J Clin Orthop Trauma       Date:  2020-06-17

7.  Biomechanical comparison of tigecycline loaded bone cement with vancomycin and daptomycin loaded bone cements.

Authors:  Sedit Kıvanç Muratlı; Vasfi Karatosun; Bora Uzun; İzge Günal
Journal:  Acta Orthop Traumatol Turc       Date:  2020-09       Impact factor: 1.511

8.  Mechanical and elution properties of G3 Low Viscosity bone cement loaded up to three antibiotics.

Authors:  Giorgio Cacciola; Federico De Meo; Pietro Cavaliere
Journal:  J Orthop       Date:  2018-09-06

9.  [Addition of antibiotics to bone cement for septic prosthesis exchange].

Authors:  A Zahar; P Hannah
Journal:  Oper Orthop Traumatol       Date:  2015-09-28       Impact factor: 1.154

10.  Cefazolin Irreversibly Inhibits Proliferation and Migration of Human Mesenchymal Stromal Cells.

Authors:  Hakan Pilge; Julia Fröbel; Sabine Lensing-Höhn; Christoph Zilkens; Rüdiger Krauspe
Journal:  Biomed Res Int       Date:  2016-03-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.